References

Blanchet, P.J., S. Konitsiotis and T.N. Chase, 1998. Amantadine reduces levodopa-induced dyskinesiasin parkinsonian monkeys. Mov. Disord., 13: 798-802.
PubMed  |  

Dawklns, A.T., L.R. Giager, Y. Togo, R.B. Hornick and B.A. Harris, 1968. Studies on induced influenza inman. II. Double-blind study designed to assess the prophylacticefficacy of an analogue of amantadine hydrochloride. J. Am. Med. Assoc., 203: 1095-1099.

Galbraith, A.W., 1975. Therapeutic trials of amantadine (symmetrel) in general practice. J. Antimicrob. Chemother., 1: 81-86.

Hoffman, C.E., 1980. Amantadine HCI and Related Compounds. In: Selectiveinhibitors of Viral Functions, Carter, W.A. (Ed.). CRC Press, Cleveland, Ohio, pp: 199-211.

Jackson, G.G. and E.D. Stanley, 1976. Prevention and control of influenza by chemoprophylaxis and chemotherapy. Prospects from examination of recent experience. J. Am. Med. Assoc., 235: 2739-2742.
PubMed  |  

Jackson, G.G., E.D. Stanley and R.L. Mkldoon, 1967. Chemoprophylaxis of viral respiratory diseases. Bull. Pan. Am. Health Org., 147: 595-603.

Metman, L.V., P. Del Dotto, P. van den Munckhof, J. Fang, M.M. Mouradian and T.N. Chase, 1998. Amantadine as treatment for dyskinesias and motor fluctuationsin Parkinson's disease. Neurology, 50: 1323-1326.
Direct Link  |  

Monto, A.S., R.A. Gunn, M.G. Bandyk and C.L. King, 1979. Prevention of Russian influenza by amantadine. J. Am. Med. Assoc., 241: 1003-1007.
PubMed  |  

Peckinpaugh, R.O., F.B. Askin, W.E. Pierce, E.A. Edwards, D.P. Johnson and G.G. Jackson, 1970. Fieldstudies with amantadine: Acceptability and protection. Ann. N.Y. Acad. Sci., 173: 62-73.
CrossRef  |  

Rablnovich, S., J.T. Baldinin and R. Banniter, 1969. Treatment of influenza: The therapeutic efficacy of rimantadine HCI in naturally occurring influenza A2 outbreak. Am. J. Med. Sci., 257: 328-335.

Schwab, R.S., A.C. England Jr., D.C. Poskanzer and R.R. Young, 1969. Amantadine in the treatment of Parkinson's disease. J. Am. Med. Assco., 208: 1168-1170.

Schwab, R.S., D.C. Poskanzer, A.C. Endland and R.R. Young, 1972. Amantadine in Parkinson's disease. Review of more than two years experience. J. Am. Med. Assoc., 222: 792-795.
PubMed  |  

Singer, C., S. Papapetropoulos, G. Uzcategui and L. Vela, 2006. The use of amantadine HCL in clinical practice: A study of old and new indications. J. Applied Res., 6: 240-245.
Direct Link  |  

Van Voris, L.P., R.F. Betts, F.G. Hayden, W.A. Christma and R.G. Dougls, 1981. Successful treatment ofnatually occurring influenza A/USSR/77/H1N1. J. Am.Med. Assoc., 245: 1128-1131.
PubMed  |  

Wingleld, W.L., D. Pollack and R.R. Grunert, 1969. Therapeutic efficacy of amantadine HCI and rimantadine HCI in naturally occurring influenza A2 respiratory illnessin man. N. Engl. J. Med., 281: 579-584.
Direct Link  |